Used in the evaluation of canine conjunctivitis to diagnose tear deficiency as a contributing factor to ocular surface diseases and to assess lacrimal gland function.
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORESelect the link below that best describes you and we'll point you in the right direction
Discover Solutions available for your pet in your country
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)Belgium (French)
Brazil
Canada (English)Canada (French)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)Switzerland (German)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Yemen
Global